Clinical trial
Randomized, Double-Blind, Crossover, Comparator Pilot Study of DFN-11 Injection (Strength A vs. Strength B) for Rapidly Escalating Migraine
NCT02571049 is registered in ClinicalTrials.gov with Dr. Reddy's Laboratories Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double-Blind, Crossover, Comparator Pilot Study of DFN-11 Injection (Strength A vs. Strength B) for Rapidly Escalating Migraine
- Lead sponsor
- Dr. Reddy's Laboratories Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- May 31, 2016
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rapidly escalating migraine